X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22245) 22245
Newsletter (505) 505
Book Chapter (86) 86
Newspaper Article (72) 72
Magazine Article (67) 67
Dissertation (36) 36
Conference Proceeding (9) 9
Book Review (8) 8
Publication (8) 8
Web Resource (8) 8
Book / eBook (3) 3
Journal / eJournal (1) 1
Reference (1) 1
Report (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
infliximab (20244) 20244
humans (15105) 15105
female (8485) 8485
male (8287) 8287
adult (6647) 6647
antibodies, monoclonal - therapeutic use (6386) 6386
middle aged (6070) 6070
tumor necrosis factor-alpha - antagonists & inhibitors (5235) 5235
gastroenterology & hepatology (4847) 4847
treatment outcome (4677) 4677
etanercept (4634) 4634
rheumatology (4329) 4329
adalimumab (4324) 4324
therapy (3740) 3740
crohn's disease (3291) 3291
rheumatoid arthritis (3217) 3217
aged (3112) 3112
antirheumatic agents - therapeutic use (3036) 3036
arthritis, rheumatoid - drug therapy (2874) 2874
crohns-disease (2785) 2785
crohn disease - drug therapy (2758) 2758
antibodies, monoclonal - adverse effects (2691) 2691
inflammatory-bowel-disease (2667) 2667
rheumatoid-arthritis (2616) 2616
inflammatory bowel disease (2422) 2422
ulcerative colitis (2327) 2327
efficacy (2248) 2248
monoclonal antibodies (2239) 2239
care and treatment (2111) 2111
methotrexate (2092) 2092
adolescent (2065) 2065
double-blind (2013) 2013
retrospective studies (1881) 1881
young adult (1838) 1838
severity of illness index (1812) 1812
drug therapy (1735) 1735
pharmacology & pharmacy (1714) 1714
arthritis (1686) 1686
dermatology (1680) 1680
anti-inflammatory agents - therapeutic use (1679) 1679
tumor necrosis factor-α (1655) 1655
immunosuppressive agents - therapeutic use (1642) 1642
psoriasis (1601) 1601
patients (1597) 1597
immunoglobulin g - therapeutic use (1563) 1563
antibodies, monoclonal - administration & dosage (1555) 1555
receptors, tumor necrosis factor - therapeutic use (1555) 1555
safety (1532) 1532
gastrointestinal agents - therapeutic use (1480) 1480
necrosis-factor-alpha (1450) 1450
infliximab - therapeutic use (1443) 1443
tumor necrosis factor (1439) 1439
medicine & public health (1429) 1429
drug therapy, combination (1392) 1392
disease (1376) 1376
research (1370) 1370
risk factors (1364) 1364
antirheumatic agents - adverse effects (1355) 1355
follow-up studies (1304) 1304
colitis, ulcerative - drug therapy (1283) 1283
immunology (1270) 1270
medicine, general & internal (1230) 1230
child (1226) 1226
ulcerative-colitis (1226) 1226
antibodies, monoclonal, humanized (1201) 1201
tumor necrosis factor-tnf (1187) 1187
remission (1169) 1169
inflammation (1162) 1162
tumor-necrosis-factor (1156) 1156
abridged index medicus (1120) 1120
management (1117) 1117
inflammatory bowel diseases - drug therapy (1088) 1088
time factors (1071) 1071
prospective studies (1066) 1066
surgery (1062) 1062
animals (1061) 1061
analysis (1059) 1059
azathioprine (1043) 1043
remission induction (1017) 1017
tnf-alpha (1012) 1012
tumor necrosis factor-alpha - immunology (1012) 1012
psoriasis - drug therapy (972) 972
health aspects (960) 960
ankylosing spondylitis (958) 958
medical research (953) 953
antibodies, monoclonal, humanized - therapeutic use (948) 948
methotrexate - therapeutic use (922) 922
inflammatory bowel diseases (920) 920
monoclonal-antibody (911) 911
trial (909) 909
risk (898) 898
antibodies (889) 889
diagnosis (880) 880
dosage and administration (872) 872
maintenance therapy (844) 844
medicine, experimental (842) 842
children (835) 835
crohn disease - complications (821) 821
anti-inflammatory agents, non-steroidal - therapeutic use (795) 795
rheumatoid factor (784) 784
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (20909) 20909
German (417) 417
Spanish (415) 415
French (412) 412
Japanese (314) 314
Korean (136) 136
Russian (111) 111
Portuguese (101) 101
Italian (75) 75
Polish (74) 74
Chinese (43) 43
Hungarian (42) 42
Danish (38) 38
Czech (36) 36
Dutch (28) 28
Turkish (28) 28
Croatian (12) 12
Slovak (12) 12
Hebrew (10) 10
Swedish (9) 9
Finnish (5) 5
Norwegian (5) 5
Icelandic (4) 4
Persian (2) 2
Romanian (2) 2
Serbian (2) 2
Slovenian (2) 2
Greek (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Pediatric Gastroenterology and Nutrition, ISSN 0277-2116, 04/2017, Volume 64, Issue 4, pp. 580 - 585
Journal Article
Gut, ISSN 0017-5749, 10/2015, Volume 64, Issue 10, pp. 1539 - 1545
Journal Article
Alimentary pharmacology & therapeutics, ISSN 0269-2813, 2017, Volume 46, Issue 11-12, pp. 1037 - 1053
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2017, Volume 76, Issue 1, pp. 58 - 64
Journal Article
Journal Article
Arthritis research & therapy, ISSN 1478-6362, 2016, Volume 18, Issue 1, p. 25
Background: CT-P13 (Remsima (R), Inflectra (R)) is a biosimilar of the infliximab reference product (RP; Remicade (R)) and is approved in Europe and elsewhere,... 
Immunogenicity | Infliximab | Clinical trial | Efficacy | ASAS | Safety | CT-P13 | Pharmacokinetics | Ankylosing spondylitis | Biosimilar | MULTICENTER | INNOVATOR INFLIXIMAB | ACTIVE RHEUMATOID-ARTHRITIS | METHOTREXATE | MONOCLONAL-ANTIBODY | RHEUMATOLOGY | 2010 UPDATE | SPONDYLOARTHRITIS | RECOMMENDATIONS | DOUBLE-BLIND | PLACEBO-CONTROLLED TRIAL | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Infliximab - therapeutic use | Infliximab - pharmacokinetics | Young Adult | Infliximab - adverse effects | Antirheumatic Agents - adverse effects | Biosimilar Pharmaceuticals - pharmacokinetics | Adult | Female | Neutropenia - chemically induced | Antirheumatic Agents - therapeutic use | Biosimilar Pharmaceuticals - therapeutic use | Double-Blind Method | Spondylitis, Ankylosing - drug therapy | Antibodies, Monoclonal - pharmacokinetics | Treatment Outcome | Spondylitis, Ankylosing - metabolism | Biosimilar Pharmaceuticals - adverse effects | Self Report - standards | Spondylitis, Ankylosing - diagnosis | Internationality | Adolescent | Antirheumatic Agents - pharmacokinetics | Aged | Chemical and Drug Induced Liver Injury | Longitudinal Studies | Complications and side effects | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Dosage and administration | Research | Drug therapy | Methods
Journal Article